ArticleNature machine intelligence2024
Reusability report: Leveraging supervised learning to uncover phenotype-relevant biology from single-cell RNA sequencing data.
Article in Nature machine intelligence, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Hallmarks of artificial intelligence contributions to precision oncology.Nature cancer · 2025Review
- Gene signatures for cancer research: A 25-year retrospective and future avenues.PLoS computational biology · 2024Article
- Identifying cell types by lasso-constraint regularized Gaussian graphical model based on weighted distance penalty.Briefings in bioinformatics · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Recent advances in single-cell transcriptome sequencing and computational analysis methods have improved our understanding of cellular heterogeneity. However, associating different cell subsets with phenotypes remains challenging. Recently, Ren et al. introduced PENCIL, a supervised learning framework incorporating gene selection to discern phenotype-relevant cells. To assess PENCIL's reproducibility and transferability, we conducted a comprehensive evaluation across 12 single-cell RNA sequencing datasets representing four distinct phenotypes. We identified a few caveats with the original version of PENCIL, such as sensitivity to input perturbation, the correction of which contributed to PENCIL's enhanced reproducibility. We highlight that boosting PENCIL's cell subsets identification with gene set variation analysis creates a cytotoxic T cell immunotherapy response signature (CyTIR) predictive of immune checkpoint blockade response in skin cancer across multiple datasets, with an area under curve >0.75 and accuracy >0.71. Overall, our assessments enhance PENCIL's reproducibility and utility, further extending its potential for identifying phenotype-relevant cell subsets in diverse biomedical applications.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.